Correlation Between National Research and Medical Cannabis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both National Research and Medical Cannabis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining National Research and Medical Cannabis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between National Research Corp and Medical Cannabis Pay, you can compare the effects of market volatilities on National Research and Medical Cannabis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in National Research with a short position of Medical Cannabis. Check out your portfolio center. Please also check ongoing floating volatility patterns of National Research and Medical Cannabis.

Diversification Opportunities for National Research and Medical Cannabis

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between National and Medical is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding National Research Corp and Medical Cannabis Pay in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medical Cannabis Pay and National Research is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on National Research Corp are associated (or correlated) with Medical Cannabis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medical Cannabis Pay has no effect on the direction of National Research i.e., National Research and Medical Cannabis go up and down completely randomly.

Pair Corralation between National Research and Medical Cannabis

Considering the 90-day investment horizon National Research Corp is expected to under-perform the Medical Cannabis. But the stock apears to be less risky and, when comparing its historical volatility, National Research Corp is 126.37 times less risky than Medical Cannabis. The stock trades about -0.09 of its potential returns per unit of risk. The Medical Cannabis Pay is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest  0.01  in Medical Cannabis Pay on September 1, 2024 and sell it today you would earn a total of  0.00  from holding Medical Cannabis Pay or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

National Research Corp  vs.  Medical Cannabis Pay

 Performance 
       Timeline  
National Research Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days National Research Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Medical Cannabis Pay 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Medical Cannabis Pay are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady technical and fundamental indicators, Medical Cannabis reported solid returns over the last few months and may actually be approaching a breakup point.

National Research and Medical Cannabis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with National Research and Medical Cannabis

The main advantage of trading using opposite National Research and Medical Cannabis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if National Research position performs unexpectedly, Medical Cannabis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medical Cannabis will offset losses from the drop in Medical Cannabis' long position.
The idea behind National Research Corp and Medical Cannabis Pay pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years